According to a recent market study published by Growth Market Reports, titled, "Global Bacillus Subtilis Market by forms, product types, end use industry, and regions: Size, Share, Trends and Opportunity Analysis, 2017-2027", the market was valued at USD 71.2 Million in 2019 and is expected to grow at a healthy growth rate of 7.8% by the year 2027.

Bacillus subtilis produces medically useful antibiotics. It is widely used in the production of heterologous proteins and has excellent physiological properties and easy-to-adapt metabolism, making it easy to grow on cheap substrates. It is an important industrial organism. It secretes proteins and produces fine chemicals. It is a stimulant for plant growth. It produces endospores, which help in studying several major cell development issues, including asymmetry production, cell fate determination, and morphogenesis.

Global bacillus subtilis market has been fragmented based on forms, product type, end use industry, and by region. In terms of forms, the global bacillus subtilis market is categorized as liquid, powder, and paste. Based on product type, the market is classified as <100 billion CFU/g, 100–300 billion CFU/g, and > 300 billion CFU/g. On the basis of end use industry, market is segregated as pharmaceutical industry, food & beverage industry, agriculture industry, livestock industry, and others. Based on regions, the global bacillus subtilis market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Request a free sample copy @

The market is driven by factors such as increasing demand for nontoxic products in end-use industries such as waste treatment, food & beverages, aquaculture, industrial enzymes, agriculture, and pharmaceuticals. Rising demand for bacillus subtilis in the production of membrane proteins for biomedical and biotechnology applications is expected to drive the market. However, contrary health effects and the establishment of various regulations on the development of bacillus subtilis are some of the factors limiting the market growth.

As per Growth Market Reports industry analyst Divyanka Sankhe “The bacillus subtilis market is projected to expand at a rapid pace, due to its multiple health benefits such as improved liver disorder, reduced risk of cancer, protection against infections and allergies, and decreased obesity. Companies are adopting various strategies to gain competitive advantages. Key players are focusing on product development, which increases the demand for bacillus subtilis.”

The effect of COVID-19 pandemic situation has led to the closure of several non-essential businesses reducing the demand for industrial goods in the world, which in turn, is affecting several industries worldwide. The COVID-19 pandemic did not hamper R&D of bacillus subtilis, as it is used in the treatment of various diseases and ailments. Manufacturers in the market were focused on investing in COVID-19 related products. Bacillus subtilis got government approvals, as it has the ability to combat multiple viral diseases including COVID-19. It is used in manufacturing COVID-19 vaccines. Demand for bacillus subtilis increased during the pandemic, due to its multiple benefits in increasing the immunity of people during the lockdown period.

Key Takeaways from the Study

  • Asia Pacific is anticipated to hold a substantial share of the market and is expected to grow at a considerable CAGR during the forecast period. It constituted 38.7% share of the market in 2020.
  • The powder form is expected to hold a significant share of the market during the forecast period. The liquid form is anticipated to grow at a substantial CAGR during the forecast period. Increasing usage of liquid bacillus subtilis in the food & beverage industry, the pharmaceutical industry, and the bio-chemical industry is a major factor propelling the segment.
  • The <100 billion CGU/segment is expected to dominate the market, owing to increasing consumption of <100 billion CGU bacillus subtilis in aquatic animal feeding and feed additives for poultry applications.
  • The food & beverage industry segment is expected to hold a significant share of the market during the forecast period. Increasing applications of bacillus subtilis in various industries are expected to fuel the demand for bacillus subtilis.

Report Scope

Report Metric


Market Value in 2019

USD 17.2 Million

Market Growth Rate (from 2020 to 2027)


Historical Data

2017 & 2018

Base Year


Forecast Period

2020 – 2027

Market Segments

Forms, Product Type, End Use Industry, And Regions



Region Scope

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Key Companies Profiled

Bayer AG, Deerland Probiotics & Enzymes, Inc, THE REAL IPM CO.(KENYA) LTD (BIOBEST GROUP), Aumgene Biosciences, Wuhan Kernel Bio-tech Co., Ltd., Meteoric Biopharmaceuticals Pvt. Ltd., BASF SE, Manidharma Biotech Private Limited, Lonza, AgriLife, Anand Agro Care, and Merck KGaA

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail tailor-made purchase options to meet your research requirements.

Target Audience

  • Supply-side: Bacillus subtilis products manufacturers, raw material suppliers, primary respondents, and distributors.
  • Demand Side: Pharmaceutical Industry, Food & Beverage Industry, Agriculture Industry, Livestock Industry, And Others
  • Regulatory Side: Concerned government authorities, commercial research & development (R&D) institutions, and other regulatory bodies.
  • Associations and Industry Bodies: Food and Drug Administration (FDA), International Trade Centre (ITC), World Health Organization, Journal of Biomedical Science, Diseases Society of America, National Library of Medicine, and Others.